Literature DB >> 9562630

Actin-binding specificity of marine macrolide toxins, mycalolide B and kabiramide D.

S Wada1, S Matsunaga, S Saito, N Fusetani, S Watabe.   

Abstract

An actin-depolymerizing marine natural product, mycalolide B, and a related compound, kabiramide D, were labeled with biocytin, a biotin derivative, and used to specify target molecules in cultured rat 3Y1 fibroblasts. Mycalolide B exhibited the ability to bind to various intracellular proteins, probably through the Michael addition of a sulfhydryl group to C5 of mycalolide B. However, no intracellular proteins other than actin apparently reacted with biocytinylated kabiramide D, demonstrating that the binding of kabiramide D to actin was highly specific. Cells treated with biocytinylated kabiramide D followed by staining with fluorescein isothiocyanate-conjugated avidin showed that biocytinylated kabiramide D bound to stress fibers composed of F-actin, although the staining intensity was weaker than the fluorescent phalloidin staining. The assay for the binding of kabiramide D to actin, which had previously been treated with other actin-depolymerizing agents, showed that the actin-binding site for kabiramide D was the same as that for bistheonellide A, but not those for latrunculin A and cytochalasin D.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9562630     DOI: 10.1093/oxfordjournals.jbchem.a022029

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  8 in total

Review 1.  The Lithistida: important sources of compounds useful in biomedical research.

Authors:  Amy E Wright
Journal:  Curr Opin Biotechnol       Date:  2010-12       Impact factor: 9.740

2.  Exit from host cells by the pathogenic parasite Toxoplasma gondii does not require motility.

Authors:  Mark D Lavine; Gustavo Arrizabalaga
Journal:  Eukaryot Cell       Date:  2007-11-09

3.  Structures of microfilament destabilizing toxins bound to actin provide insight into toxin design and activity.

Authors:  John S Allingham; Angela Zampella; Maria Valeria D'Auria; Ivan Rayment
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-28       Impact factor: 11.205

Review 4.  Targeting the cytoskeleton against metastatic dissemination.

Authors:  Carmen Ruggiero; Enzo Lalli
Journal:  Cancer Metastasis Rev       Date:  2021-01-20       Impact factor: 9.264

5.  Molecular docking and QSAR of aplyronine A and analogues: potent inhibitors of actin.

Authors:  Abrar Hussain; James L Melville; Jonathan D Hirst
Journal:  J Comput Aided Mol Des       Date:  2009-11-05       Impact factor: 3.686

6.  Biomolecular mimicry in the actin cytoskeleton: mechanisms underlying the cytotoxicity of kabiramide C and related macrolides.

Authors:  Junichi Tanaka; Yuling Yan; Jeongeun Choi; Jihong Bai; Vadim A Klenchin; Ivan Rayment; Gerard Marriott
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-11       Impact factor: 11.205

7.  Effects of Modulating Actin Dynamics on HER2 Cancer Cell Motility and Metastasis.

Authors:  Sarah Nersesian; Rodette Williams; Daniel Newsted; Kavan Shah; Stephanie Young; P Andrew Evans; John S Allingham; Andrew W Craig
Journal:  Sci Rep       Date:  2018-11-22       Impact factor: 4.379

Review 8.  Macrolides: From Toxins to Therapeutics.

Authors:  Kiersten D Lenz; Katja E Klosterman; Harshini Mukundan; Jessica Z Kubicek-Sutherland
Journal:  Toxins (Basel)       Date:  2021-05-12       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.